Clinical Trials in San Antonio

Showing 12121-12140 of 12,572 trials

Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)

NCT00146666

The purpose of this study is to determine whether 12 weeks of daily home use of the FM220 in the most affected leg of patients with PAD and claudication, will improve peak walking time (PWT) at three months as compared with a non-treated control group.

Peripheral Arterial DiseaseIntermittent Claudication

FlowMedic90 participantsStarted Sep 2005

Jacksonville, Florida, United States • San Antonio, Texas, United States

UNKNOWNNA< 1 mile

"Efficacy in Adolescents of Continued Behavior Modification Following a Six Month Sibutramine-based Weight Management Intervention"

NCT01023139

There are few studies that look at sustained weight loss in the adolescent population. This study uses a multidisciplinary approach along with pharmacotherapy (use of Meridia)to motivate and establish behavior changes in adolescents (12-18yo) during the first phase of the study. The second phase will have those who have lost at least 5% BMI to be randomized into one of two groups. This first group will have no intervention and will be followed at 3 and 6 months to assess for weight loss maintenance. The second group will continue on with monthly behavior modifications and also be evaluated at 3 and 6 months. The hypothesis proposed is that, 1)there will be sustained weight loss at the end of one year in both arms as compared to baseline BMI, 2) and the arm with the behavioral therapy intervention will be more successful than no intervention at weight loss maintenance.

Obesity

Brooke Army Medical Center100 participantsStarted Apr 2009

San Antonio, Texas, United States • San Antonio, Texas, United States

COMPLETEDPhase 1< 1 mile

To Evaluate the Bioavailability of a Tablet of AZD1656

NCT00817505

To evaluate the bioavailability of a tablet of AZD1656.

Type 1 Diabetes

AstraZeneca11 participantsStarted Dec 2008

San Antonio, Texas, United States

Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)

"Efficacy in Adolescents of Continued Behavior Modification Following a Six Month Sibutramine-based Weight Management Intervention"

To Evaluate the Bioavailability of a Tablet of AZD1656

Find Trials by Condition in San Antonio

Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma

Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)

Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

Memory Impairment Study (Mild Cognitive Impairment Study)

Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age

Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML

Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer

A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring

TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)